hi vivek,
current pf includes kaveri, accelya, unichem, hawkins, page, repco, gruh. i plan to hold on to accelya, the feedback from agm is positive and the story is in tact.
my plan is to have more of the stocks that dont move with the market. i would like my stocks to move on their own based on the earnings (as much as possible). this is very important becuase of impending elections and other macros. with this in mind, i have recently looked at some of the stocks discussed here
pi ind : great business with more focus on csm. with 30-35% cagr in csm and 20% cagr in agri segment, i am tempted to add this. but one concern i have is dependance on monsoon. i already have kaveri, so one bad monsoon i dont want 2 stocks to be effected. even though csm may compensate for agri bizness, market will definitely correct based on the monsoon. even kaveri will be effected to some extent. one more concenrn i have is great bizness may not translate to great stock price. the overhang of agri sector will weigh on valuations.
vmart : focus on tier2, tier3 fashion apparel bizness. expanding fast with internal funds. but market always looks at same store growth, even if company keeps on new stores. because of tough bizness conditions in retailing, i am staying away from it
alembic pharma : i was very close to buying this last week. i was checking if it can replace (fully or partly) unichem. the valuations for unichem is attractive even with recent runup (11.5 pe), if you have 3-5 years view this is a better opportunity with multile growth drivers. growing international bizness (likely to get some crams contracts in fy15), focus on improving margins (mgmt guiding to go back to 26% from existing 19%) with internal restructuring. UK is in net profits, likely to improve bottom line, US is adding new produccts (many pending anda approvals), lot of hope on this, brazil will take more time. concern is about the mgmt execution skills. alembic on the other hand, is at much better position in the value chain, their intl bizness is growing at 30-35% and the domestic bizness at 20%. more focus on speciality bizness in domestic segment is improving margins. their intl bizness is showing lot of traction. only concern is relative valuation is high compared to unichem
avanti : frankly , didnt dive in much. stayed away becuase of my percieved risks of the bizness (virus, cyclones, anti dumping duty). even for short term opportunity looks risky (i know i could be wrong).
also i will be looking at cyclicals and economy turnaround stocks like L&T, Cummins, but this is atleast 1-2 qtr away
and then there are so many great stocks like ajanta, astral, mayur.
if alembic corrects, i may add it my portfolio. if market goes up a lot in next few months i may book some profits in hawkins, gruh, repco, page and be ready for the cyclicals